Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Viruses
|
September 27, 2025
Versatile and Scalable Nanoparticle Vaccine as a Scaffold Against Newly Emerging Influenza Viruses
Alessandro Pardini, Dominik A Rothen, Pascal S Krenger, et al.
Chemotherapy
|
March 10, 2007
Vivotif--a 'magic shield' for protection against typhoid fever and delivery of heterologous antigens
Ivaylo Gentschev, Simone Spreng, Heike Sieber, et al.
Vaccines
|
June 27, 2024
Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response
Jan M Sobczak, Irena Barkovska, Ina Balke, et al.
Vaccines
|
September 27, 2025
Targeted Lymph Node Immunization with Serotype-Specific Dengue VLP Vaccines Enhances Antibody Avidity and Specificity
Dominik A Rothen, Alessandro Pardini, Sudip Kumar Dutta, et al.
NPJ Vaccines
|
November 18, 2024
Probing novel epitopes on the Plasmodium falciparum circumsporozoite protein for vaccine development
Pascal S Krenger, Magali Roques, Anne-Cathrine S Vogt, et al.
Vaccines
|
August 29, 2024
Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes
Dominik A Rothen, Sudip Kumar Dutta, Pascal S Krenger, et al.
Vaccines
|
October 26, 2024
Correction: Rothen et al. Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes. <i>Vaccines</i> 2024, <i>12</i>, 874
Dominik A Rothen, Sudip Kumar Dutta, Pascal S Krenger, et al.
Vaccines
|
September 28, 2024
Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle Vaccines
Dominik A Rothen, Sudip Kumar Dutta, Pascal S Krenger, et al.
Allergy
|
April 11, 2022
Intranasal administration of a virus like particles-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern
Dominik A Rothen, Pascal S Krenger, Aleksandra Nonic, et al.
Allergy
|
September 8, 2021
A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2
Mona O Mohsen, Ina Balke, Simon Zinkhan, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Viruses
|
September 27, 2025
Versatile and Scalable Nanoparticle Vaccine as a Scaffold Against Newly Emerging Influenza Viruses
Alessandro Pardini, Dominik A Rothen, Pascal S Krenger, et al.
Chemotherapy
|
March 10, 2007
Vivotif--a 'magic shield' for protection against typhoid fever and delivery of heterologous antigens
Ivaylo Gentschev, Simone Spreng, Heike Sieber, et al.
Vaccines
|
June 27, 2024
Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response
Jan M Sobczak, Irena Barkovska, Ina Balke, et al.
Vaccines
|
September 27, 2025
Targeted Lymph Node Immunization with Serotype-Specific Dengue VLP Vaccines Enhances Antibody Avidity and Specificity
Dominik A Rothen, Alessandro Pardini, Sudip Kumar Dutta, et al.
NPJ Vaccines
|
November 18, 2024
Probing novel epitopes on the Plasmodium falciparum circumsporozoite protein for vaccine development
Pascal S Krenger, Magali Roques, Anne-Cathrine S Vogt, et al.
Vaccines
|
August 29, 2024
Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes
Dominik A Rothen, Sudip Kumar Dutta, Pascal S Krenger, et al.
Vaccines
|
October 26, 2024
Correction: Rothen et al. Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes. <i>Vaccines</i> 2024, <i>12</i>, 874
Dominik A Rothen, Sudip Kumar Dutta, Pascal S Krenger, et al.
Vaccines
|
September 28, 2024
Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle Vaccines
Dominik A Rothen, Sudip Kumar Dutta, Pascal S Krenger, et al.
Allergy
|
April 11, 2022
Intranasal administration of a virus like particles-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern
Dominik A Rothen, Pascal S Krenger, Aleksandra Nonic, et al.
Allergy
|
September 8, 2021
A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2
Mona O Mohsen, Ina Balke, Simon Zinkhan, et al.
Page
of 3